Logo image of HLI

HOULIHAN LOKEY INC (HLI) Stock Fundamental Analysis

USA - NYSE:HLI - US4415931009 - Common Stock

205.19 USD
-2.96 (-1.42%)
Last: 9/12/2025, 8:04:00 PM
205.19 USD
0 (0%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

6

Overall HLI gets a fundamental rating of 6 out of 10. We evaluated HLI against 238 industry peers in the Capital Markets industry. While HLI has a great profitability rating, there are some minor concerns on its financial health. HLI is valued quite expensively, but it does show have an excellent growth rating. These ratings could make HLI a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HLI had positive earnings in the past year.
HLI had a positive operating cash flow in the past year.
Each year in the past 5 years HLI has been profitable.
HLI had a positive operating cash flow in each of the past 5 years.
HLI Yearly Net Income VS EBIT VS OCF VS FCFHLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

1.2 Ratios

HLI's Return On Assets of 11.61% is amongst the best of the industry. HLI outperforms 92.02% of its industry peers.
HLI has a better Return On Equity (18.75%) than 85.71% of its industry peers.
With an excellent Return On Invested Capital value of 18.53%, HLI belongs to the best of the industry, outperforming 94.96% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HLI is significantly above the industry average of 7.61%.
The 3 year average ROIC (15.77%) for HLI is below the current ROIC(18.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.61%
ROE 18.75%
ROIC 18.53%
ROA(3y)9.29%
ROA(5y)11.19%
ROE(3y)16.47%
ROE(5y)20.47%
ROIC(3y)15.77%
ROIC(5y)19.56%
HLI Yearly ROA, ROE, ROICHLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

HLI has a Profit Margin of 16.46%. This is comparable to the rest of the industry: HLI outperforms 51.26% of its industry peers.
In the last couple of years the Profit Margin of HLI has remained more or less at the same level.
Looking at the Operating Margin, with a value of 23.16%, HLI is in line with its industry, outperforming 44.96% of the companies in the same industry.
HLI's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.16%
PM (TTM) 16.46%
GM N/A
OM growth 3Y-4.82%
OM growth 5Y3.29%
PM growth 3Y-4.63%
PM growth 5Y1.08%
GM growth 3YN/A
GM growth 5YN/A
HLI Yearly Profit, Operating, Gross MarginsHLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

6

2. Health

2.1 Basic Checks

HLI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HLI has been increased compared to 5 years ago.
The debt/assets ratio for HLI has been reduced compared to a year ago.
HLI Yearly Shares OutstandingHLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
HLI Yearly Total Debt VS Total AssetsHLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

HLI has an Altman-Z score of 8.27. This indicates that HLI is financially healthy and has little risk of bankruptcy at the moment.
HLI has a better Altman-Z score (8.27) than 89.92% of its industry peers.
The Debt to FCF ratio of HLI is 0.02, which is an excellent value as it means it would take HLI, only 0.02 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.02, HLI belongs to the best of the industry, outperforming 93.28% of the companies in the same industry.
HLI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
HLI has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. HLI outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.02
Altman-Z 8.27
ROIC/WACCN/A
WACCN/A
HLI Yearly LT Debt VS Equity VS FCFHLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 0.97 indicates that HLI may have some problems paying its short term obligations.
HLI has a Current ratio (0.97) which is comparable to the rest of the industry.
A Quick Ratio of 0.97 indicates that HLI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.97, HLI is in line with its industry, outperforming 44.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
HLI Yearly Current Assets VS Current LiabilitesHLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.38% over the past year.
HLI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.36% yearly.
The Revenue has grown by 23.31% in the past year. This is a very strong growth!
Measured over the past years, HLI shows a quite strong growth in Revenue. The Revenue has been growing by 15.56% on average per year.
EPS 1Y (TTM)49.38%
EPS 3Y-4.01%
EPS 5Y14.36%
EPS Q2Q%75.41%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y1.72%
Revenue growth 5Y15.56%
Sales Q2Q%17.86%

3.2 Future

HLI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.26% yearly.
HLI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.03% yearly.
EPS Next Y23.22%
EPS Next 2Y18.71%
EPS Next 3Y16.26%
EPS Next 5YN/A
Revenue Next Year14.48%
Revenue Next 2Y14.48%
Revenue Next 3Y13.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HLI Yearly Revenue VS EstimatesHLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
HLI Yearly EPS VS EstimatesHLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 28.50 indicates a quite expensive valuation of HLI.
Based on the Price/Earnings ratio, HLI is valued a bit more expensive than 67.65% of the companies in the same industry.
HLI's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
HLI is valuated rather expensively with a Price/Forward Earnings ratio of 23.19.
HLI's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HLI is more expensive than 61.76% of the companies in the same industry.
HLI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.73.
Industry RankSector Rank
PE 28.5
Fwd PE 23.19
HLI Price Earnings VS Forward Price EarningsHLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLI is valued a bit cheaper than the industry average as 71.85% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.51
EV/EBITDA 21.9
HLI Per share dataHLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

HLI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of HLI may justify a higher PE ratio.
HLI's earnings are expected to grow with 16.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.23
PEG (5Y)1.98
EPS Next 2Y18.71%
EPS Next 3Y16.26%

5

5. Dividend

5.1 Amount

HLI has a Yearly Dividend Yield of 1.15%. Purely for dividend investing, there may be better candidates out there.
HLI's Dividend Yield is slightly below the industry average, which is at 7.96.
With a Dividend Yield of 1.15, HLI pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

On average, the dividend of HLI grows each year by 14.04%, which is quite nice.
HLI has been paying a dividend for at least 10 years, so it has a reliable track record.
HLI has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)14.04%
Div Incr Years9
Div Non Decr Years9
HLI Yearly Dividends per shareHLI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

HLI pays out 40.76% of its income as dividend. This is a bit on the high side, but may be sustainable.
HLI's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP40.76%
EPS Next 2Y18.71%
EPS Next 3Y16.26%
HLI Yearly Income VS Free CF VS DividendHLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
HLI Dividend Payout.HLI Dividend Payout, showing the Payout Ratio.HLI Dividend Payout.PayoutRetained Earnings

HOULIHAN LOKEY INC

NYSE:HLI (9/12/2025, 8:04:00 PM)

After market: 205.19 0 (0%)

205.19

-2.96 (-1.42%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners100.11%
Inst Owner Change1.05%
Ins Owners0.13%
Ins Owner Change2.78%
Market Cap14.43B
Analysts70
Price Target211.55 (3.1%)
Short Float %1.65%
Short Ratio2.19
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly Dividend2.38
Dividend Growth(5Y)14.04%
DP40.76%
Div Incr Years9
Div Non Decr Years9
Ex-Date09-02 2025-09-02 (0.6)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.99%
Min EPS beat(2)19.63%
Max EPS beat(2)26.35%
EPS beat(4)4
Avg EPS beat(4)15.86%
Min EPS beat(4)7.29%
Max EPS beat(4)26.35%
EPS beat(8)8
Avg EPS beat(8)9.85%
EPS beat(12)10
Avg EPS beat(12)8%
EPS beat(16)14
Avg EPS beat(16)12.2%
Revenue beat(2)2
Avg Revenue beat(2)5.22%
Min Revenue beat(2)4.85%
Max Revenue beat(2)5.6%
Revenue beat(4)4
Avg Revenue beat(4)5.15%
Min Revenue beat(4)4.31%
Max Revenue beat(4)5.83%
Revenue beat(8)7
Avg Revenue beat(8)3.41%
Revenue beat(12)9
Avg Revenue beat(12)2.62%
Revenue beat(16)13
Avg Revenue beat(16)6.94%
PT rev (1m)2.47%
PT rev (3m)15.01%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)3.51%
EPS NY rev (1m)8.32%
EPS NY rev (3m)9.46%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)3.88%
Revenue NY rev (1m)2.29%
Revenue NY rev (3m)2.6%
Valuation
Industry RankSector Rank
PE 28.5
Fwd PE 23.19
P/S 5.81
P/FCF 19.51
P/OCF 18.46
P/B 6.62
P/tB 21.25
EV/EBITDA 21.9
EPS(TTM)7.2
EY3.51%
EPS(NY)8.85
Fwd EY4.31%
FCF(TTM)10.52
FCFY5.13%
OCF(TTM)11.11
OCFY5.42%
SpS35.29
BVpS30.97
TBVpS9.66
PEG (NY)1.23
PEG (5Y)1.98
Profitability
Industry RankSector Rank
ROA 11.61%
ROE 18.75%
ROCE 25.21%
ROIC 18.53%
ROICexc 28.43%
ROICexgc N/A
OM 23.16%
PM (TTM) 16.46%
GM N/A
FCFM 29.8%
ROA(3y)9.29%
ROA(5y)11.19%
ROE(3y)16.47%
ROE(5y)20.47%
ROIC(3y)15.77%
ROIC(5y)19.56%
ROICexc(3y)27.01%
ROICexc(5y)39.46%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.46%
ROCE(5y)26.61%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.39%
ROICexc growth 5Y3.92%
OM growth 3Y-4.82%
OM growth 5Y3.29%
PM growth 3Y-4.63%
PM growth 5Y1.08%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.02
Debt/EBITDA 0.02
Cap/Depr 86.79%
Cap/Sales 1.69%
Interest Coverage 444.85
Cash Conversion 125.41%
Profit Quality 181.11%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 8.27
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)139.05%
Cap/Depr(5y)105.57%
Cap/Sales(3y)2.65%
Cap/Sales(5y)1.85%
Profit Quality(3y)109.81%
Profit Quality(5y)135.31%
High Growth Momentum
Growth
EPS 1Y (TTM)49.38%
EPS 3Y-4.01%
EPS 5Y14.36%
EPS Q2Q%75.41%
EPS Next Y23.22%
EPS Next 2Y18.71%
EPS Next 3Y16.26%
EPS Next 5YN/A
Revenue 1Y (TTM)23.31%
Revenue growth 3Y1.72%
Revenue growth 5Y15.56%
Sales Q2Q%17.86%
Revenue Next Year14.48%
Revenue Next 2Y14.48%
Revenue Next 3Y13.03%
Revenue Next 5YN/A
EBIT growth 1Y49.24%
EBIT growth 3Y-3.18%
EBIT growth 5Y19.36%
EBIT Next Year26.68%
EBIT Next 3Y21.87%
EBIT Next 5YN/A
FCF growth 1Y237.97%
FCF growth 3Y3.58%
FCF growth 5Y24.82%
OCF growth 1Y178.41%
OCF growth 3Y4.83%
OCF growth 5Y24.15%